It is expected that domestic researchers will speed up the development of a new fibrosis treatment by uncovering the mechanism of action of Bersiporocin, which is being developed as a treatment for idiopathic pulmonary fibrosis. Yonsei University Professor Seong-Hoon Kim and Dr. Ina Yoon's research team conducted joint research with Professor Kwang-Yeon Hwang (Department of Biotechnology) of Korea University to identify the molecular mechanism that can explain the efficacy and safety of Bersiporocin at the same time. The research results were published in the world-renowned medical journal ‘EMBO Molecular Medicine’ on the 22nd (local time).

Idiopathic pulmonary fibrosis is an incurable disease in whi